Leaflet: Information for the user
Akitex 5 mg EFG tablets
Akitex 10 mg EFG tablets
Akitex 15 mg EFG tablets
aripiprazole
Read this leaflet carefully before starting to take this medicine, as it contains important information for you.
Contents of the pack and other information
5 Storage of Akitex
Akitex contains the active substance aripiprazole and belongs to a group of medicines called antipsychotics.
It is used to treat adults and adolescents aged 15 and older who suffer from a disease characterized by symptoms such as hearing, seeing, and feeling things that do not exist, distrust, false beliefs, incoherent speech, and emotional and behavioral monotony. People in this state may also feel depressed, guilty, restless, or tense.
Aripiprazole is used to treat adults and adolescents aged 13 and older who suffer from a disorder characterized by symptoms such as feeling euphoric, having excessive energy, needing to sleep much less than usual, talking very quickly with flight of ideas, and sometimes severe irritability. In adults, it also prevents this situation in patients who have responded to treatment with aripiprazole.
Do not take Akitex
Warnings and precautions
Talk to your doctor before starting to take this medicine.
There have been reports of patients experiencing suicidal thoughts and behaviors during treatment with aripiprazole. Tell your doctor immediately if you have thoughts or feelings of harming yourself.
Before starting treatment with aripiprazole, tell your doctor if you suffer from
If you notice that you are gaining weight, developing unusual movements, experiencing somnolence that interferes with your daily activities, having difficulty swallowing, or presenting allergic symptoms, please inform your doctor.
If you suffer from dementia (loss of memory and other mental abilities), you or the person caring for you or a family member should inform your doctor if you have ever had a stroke or "mini" stroke.
Talk to your doctor immediately if you have thoughts or feelings of harming yourself. There have been reports of patients experiencing suicidal thoughts and behaviors during treatment with aripiprazole.
Talk to your doctor immediately if you notice numbness or stiffness of the muscles with high fever, sweating, altered mental state, or a very fast or irregular heartbeat.
Tell your doctor if you, your family, or caregiver notice that you are developing impulses or urges to behave in an unusual way and cannot resist the impulse, instinct, or temptation to carry out certain activities that may harm you or others. This is called impulse control disorder and may include behaviors such as gambling addiction, excessive eating or spending, abnormally high sexual appetite, or concern about an increase in sexual thoughts and feelings.
Your doctor may consider adjusting or interrupting the dose.
Aripiprazole may cause somnolence, a drop in blood pressure when standing up, dizziness, and changes in the ability to move and maintain balance, which could lead to falls. Caution should be exercised, especially if you are an elderly patient or suffer from weakness.
Children and adolescents
Do not use this medicine in children and adolescents under 13 years of age. It is not known if it is safe and effective in these patients.
Other medicines and Akitex
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those without a prescription.
Medicines that lower blood pressure: aripiprazole may increase the effect of medicines used to lower blood pressure. Make sure to tell your doctor if you use any medicine to control blood pressure.
If you are taking aripiprazole with another medicine, it may mean that your doctor needs to change your dose of aripiprazole or the other medicine. It is especially important that you mention to your doctor if you are taking:
These medicines may increase the risk of side effects or reduce the effect of aripiprazole; if you notice any unusual symptoms when taking any of these medicines at the same time as aripiprazole, you should tell your doctor.
Medicines that increase serotonin levels are commonly used in diseases that include depression, generalized anxiety disorder, obsessive-compulsive disorder (OCD), and social phobia, as well as migraine and pain:
These medicines may increase the risk of side effects; if you notice any unusual symptoms when taking any of these medicines at the same time as aripiprazole, you should tell your doctor.
Taking Akitex with food, drinks, and alcohol
This medicine can be taken with or without food.
Alcohol consumption should be avoided.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
The following symptoms may occur in newborn babies of mothers who have been treated with aripiprazole in the last trimester of pregnancy (last three months of pregnancy): tremors, stiffness, and/or muscle weakness, somnolence, agitation, breathing problems, and difficulty feeding. If your baby develops any of these symptoms, you should contact your doctor.
If you are taking aripiprazole, your doctor will discuss with you whether you should breastfeed, considering the benefit of treatment for you and the benefit of breastfeeding for your baby. If you are being treated with aripiprazole, you should not breastfeed. Talk to your doctor about the best way to feed your baby if you are taking this medicine.
Driving and using machines
During treatment with this medicine, dizziness and vision problems (see section 4) may occur. This should be taken into account when requiring maximum attention, for example, when driving or operating machinery.
Akitex contains aspartame
Akitex 5 mg EFG tablets:
This medicine contains 1 mg of aspartame in each tablet.
Akitex 10 mg EFG tablets:
This medicine contains 2 mg of aspartame in each tablet.
Akitex 15 mg EFG tablets:
This medicine contains 3 mg of aspartame in each tablet.
Aspartame contains a source of phenylalanine that may be harmful in cases of phenylketonuria (PKU), a rare genetic disorder in which phenylalanine accumulates because the body is unable to eliminate it properly.
Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. If you are unsure, ask your doctor or pharmacist again.
The recommended dose for adults is 15 mg once a day. However, your doctor may prescribe lower or higher doses up to a maximum of 30 mg once a day.
Use in children and adolescents
This medicine should be started with the oral solution (liquid) at a low dose.
The dose can be gradually increased to the recommended dose for adolescents of 10 mg once a day. However, your doctor may prescribe lower or higher doses up to a maximum of 30 mg once a day.
If you think the effect of aripiprazole is too strong or too weak, tell your doctor or pharmacist.
Try to take aripiprazole at the same time each day. It does not matter if you take it with or without food. Always take the tablets with water and swallow them whole.
Even if you feel better, do not change or interrupt the daily dose of aripiprazole without consulting your doctor first.
If you take more Akitex than you should
If you realize that you have taken more aripiprazole than your doctor recommended (or if someone else has taken part of your aripiprazole), contact your doctor immediately. If you cannot contact your doctor, go to the nearest hospital and take the package with you.
Patients who have taken too much aripiprazole have experienced the following symptoms:
Other symptoms may include:
Contact your doctor or the nearest hospital immediately if you experience any of the above symptoms.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91.562.04.20, indicating the medicine and the amount ingested.
If you forget to take Akitex
If you forget a dose, take the forgotten dose as soon as you remember, but do not take a double dose to make up for forgotten doses.
If you stop taking Akitex
Do not stop your treatment just because you feel better. It is important that you continue taking this medicine for the time your doctor has indicated.
If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
Frequent adverse effects (may affect up to 1 in 10 patients):
Uncommon adverse effects (may affect up to 1 in 100 patients):
The following adverse effects have been reported during the post-marketing phase of oral aripiprazole, but the frequency of occurrence is unknown:
Inform your doctor if you experience any of these behaviors; he will explain how to manage or reduce the symptoms.
In elderly patients with dementia, a higher number of fatal cases have been reported while taking aripiprazole. Additionally, cases of stroke or "mini" stroke have been reported.
Other Adverse Effects in Children and Adolescents
Adolescents 13 years or older experienced adverse effects similar in frequency and type to those of adults, except for drowsiness, spasms, or uncontrolled contractions, restlessness, and fatigue, which were very frequent (affecting more than 1 in 10 patients), and upper abdominal pain, dry mouth, increased heart rate, weight gain, increased appetite, muscle fasciculations, involuntary movements of the limbs, and dizziness, especially when standing up after sitting or lying down, which were frequent (affecting up to 1 in 10 patients).
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date stated on the packaging after CAD. The expiration date is the last day of the month indicated.
This medicine does not require special storage conditions.
Medicines should not be disposed of through wastewater or household waste. Deposit the packaging and unused medicines in the SIGRE collection point at the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and unused medicines. This will help protect the environment.
Akitex Composition
Akitex 5 mg EFG tablets: Each tablet contains 5 mg of aripiprazole.
Akitex 10 mg EFG tablets: Each tablet contains 10 mg of aripiprazole.
Akitex 15 mg EFG tablets: Each tablet contains 15 mg of aripiprazole.
Akitex 10 mg and 15 mg, also contain:
Mint flavor.
Product Appearance and Packaging Contents
Akitex 5 mg tablets are white or off-white, oval, biconvex, with the legend "5" engraved on one side and smooth on the other. The tablet dimensions are 6.3 mm in length and 3.1 mm in width.
Akitex 10 mg tablets are white or off-white, oval, with the legend "ZE 4" engraved on one side and smooth on the other. The tablet dimensions are 8 mm in length and 4 mm in width.
Akitex 15 mg tablets are white or off-white, round, biconvex, with the legend "ZE 14" engraved on one side and smooth on the other. The tablet diameter is 7.5 mm.
OPA/Aluminum/PVC-Aluminum blisters. Packages containing 28 tablets.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Laboratorios Combix, S.L.U.
C/ Badajoz 2, Edificio 2
28223 Pozuelo de Alarcón (Madrid)
Spain
Manufacturer
Zydus France
ZAC Les Hautes Patures
Parc d'activités des Peupliers
25 Rue des Peupliers
92000 Nanterre
France
or
Centre Spécialités Pharmaceutiques
ZAC des Suzots
35 rue de la Chapelle
63450 Saint Amant Tallende
France
or
Netpharmalab Consulting Services S.L.
Carretera de Fuencarral 22,
Alcobendas,
28108 Madrid
Spain
or
Flavine Pharma France
3 Voie d’Allemagne
13127 Vitrolles
France
Date of the Last Revision of this Prospectus: October 2024
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/)